Cargando…
LABORATORY MARKERS FOR PREDICTING AGGRAVATION AND POOR PROGNOSIS IN PATIENTS WITH COVID-19
INTRODUCTION: Covid-19 is an infectious disease with systemic involvement, which causes intense changes in the blood system, such as neutrophilia and lymphopenia, as well as changes in coagulation function and the concentration of acute phase proteins. Infected patients require laboratory follow-up...
Autores principales: | Oliveira, DC, Schluga, YC, Justus, JLP, Martins, EA, Rocha, MTL, Azambuja, AP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Editora Ltda.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530580/ http://dx.doi.org/10.1016/j.htct.2021.10.083 |
Ejemplares similares
-
AVALIAÇÃO DAS SUBPOPULAÇÕES LINFOCITÁRIAS T, B E NK EM PACIENTES COM COVID-19 GRAVE ATENDIDOS EM UM HOSPITAL UNIVERSITÁRIO
por: Oliveira, D.C., et al.
Publicado: (2020) -
Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease–a report from a highly complex hospital in Brazil
por: Oliveira, Douglas Câmara de, et al.
Publicado: (2023) -
Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2021) -
Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2021) -
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)